Lupin Ltd

LUPIN13 Jun 2024
Pharmaceuticals
-0.05 (0.00%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Lupin
Lupin Ltd
Pharmaceuticals
LUPIN13 Jun 2024
-0.05 (0.00%)
1D
1M
6M
1Y
5Y
All

Lupin - Share Price & Details

Lowest Today
1601.65
Highest Today
1621
Today’s Open
1611.75
Prev. Close
1605.4
52 Week High
1727.9
52 Week Low
810
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
96.51%
Upper Circuit
Lower Circuit
P/E TTM
31.45
P/B Ratio
3.55
Traded Value(Cr)
0.00
EPS TTM
51.04
Book value
Dividend
0.50%

Price Performance

-0.14 %
1 Wk
-4.88 %
1 M
0.16 %
3 M
96.51 %
1 Y
22.30 %
YTD

Traded Volume Movement

Technical Details

Support 3
1573
Support 2
1588
Support 1
1597
Pivot Point :
1612
Resistance 1
1621
Resistance 2
1636
Resistance 3
1645

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Lupin Ltd
₹1,605.35(-0.05/0.00%)
1,605.35-0.0573,163.8496.5131.453.55
Astrazeneca Pharma India Ltd
₹6,350.95(+18.90/0.30%)
6,350.95+18.9015,877.3879.08106.2022.30
Cipla Ltd
₹1,543.45(+2.75/0.18%)
1,543.45+2.75124,617.3857.2733.554.45
Bliss GVS Pharma Ltd
₹105.35(+0.95/0.91%)
105.35+0.951,102.9236.6814.551.12
Amrutanjan Health Care Ltd
₹756.85(+4.55/0.60%)
756.85+4.552,188.1028.4948.647.58
Abbott India Ltd
₹27,612.80(+56.15/0.20%)
27,612.80+56.1558,677.2024.6548.8515.86

About Lupin Ltd

Lupin Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 73163.84 crores. It has reported a sales of Rs. 3331.72 crores and a net profit of Rs. 384.08 crores for the quarter ended December 2018. The company management includes M D Gupta, M D Gupta,Nilesh Deshbandhu Gupta.,Vinita Gupta,R V Satam,Jean-Luc Belingard,Ramesh Swaminathan,Mark D McDade,K B S Anand,Punita Kumar Sinha (Lupin Ltd) among others.
Chairman
M D Gupta
Registered office
Kalpataru Inspire 3rd Floor,Off Western Exp HW Santacruz-E,Mumbai,Maharashtra,400055
FAX :91-22-6640 8131
Background
Incorporation Year1983
Face Value₹2
Market Lot1

Latest News

Nifty 500 Q4 recap: Motilal Oswal
Nifty-500 companies reported a strong Q4 FY24 performance, driven by domestic cyclicals like BFSI and auto sectors, with 7% sales growth, 13% EBITDA increase, and 13% adjusted PAT jump, reaching Rs 35 lakh crore, Rs 6.7 lakh crore, and Rs 3.9 lakh crore respectively. Sector-wise, auto and BFSI saw 83% and 24% YoY earnings growth, while oil and gas, metals, and chemicals declined.
13 Jun 2024 | 07:07 PM
Tech View: Sideways Nifty getting primed for sharp move
Nifty reached a new all-time high of 23,481 before closing 76 points higher at Thursday's expiry, forming a small negative candle. The short-term trend remains range-bound with a positive bias, with resistance at 23,400-23,500 and support at 23,280. Analysts recommend a contrarian strategy, buying at lower extremes and selling at higher extremes, with potential upside targets of 23,900-24,000.
13 Jun 2024 | 06:47 PM
Shriram Finance Jumps 4% To Lead Nifty 50 Gainers
Nifty 50 closed 0.33% higher at 23,398.90, creating a fresh all-time high of 23,481.05 intraday, driven by lower-than-expected US inflation data. Shriram Finance led the gainers with a 4.57% increase, while Hindustan Unilever was the top loser, falling 1.6%. The realty and consumer durables sectors benefited from government initiatives, contributing to the market's modest gain.
13 Jun 2024 | 04:48 PM
Bank Nifty in sideways momentum, traders say wait and watch to trade
Bank Nifty has been trading in a sideways to consolidative momentum for the past three sessions. At 1 pm on June 13, Bank Nifty was trading at Rs 49,960, up 65 points or 0.13%. "Bank Nifty seems to be in consolidation momentum over the past few trading sessions. One should wait and watch, as it has not given any hints of a strong directional move."
13 Jun 2024 | 02:25 PM
Mid-day Mood | Nifty, Sensex off record highs
After opening at record highs, both Nifty and Sensex tapered off to trade just marginally higher on June 13. Nifty clocked a fresh high of 23,481 intraday. Sensex gained 0.8 percent to intraday high of 77,145. Nifty FMCG and Nifty Energy index were the only two laggards. All the other 11 sectoral indices were trading in green, led by the Realty index which surged over 2 percent.
13 Jun 2024 | 12:24 PM

How to buy Lupin shares on nse?

To buy Lupin shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Lupin share price today?

The Lupin shares price on nse is Rs.1605.35 today.

What is the market cap of Lupin shares on BSE ?

The company has a market capitalization of Rs.73163.84Cr

What is the PE & PB ratio of Lupin shares ?

PE is 31.45 and PB is 3.55

What is the 52 Week High and Low of Lupin shares?

Lupin stock price high: Rs.1727.9 Lupin stock price low: Rs.810

What can be the price of Lupin stocks on BSE?

As of 13:15 hours on 12th May 2023, the stock price of Lupin on the BSE was rupees 773. The price fluctuates constantly throughout trading hours. So, check for the updated price when you invest.

Is it safe to buy Lupin stocks?

Lupin is a leading name in the pharmaceutical sector. It has a market capitalization of rupees 34,804.93 crores with an average trading volume of 61,434.45. The stock might suffer price fluctuations in the short-run depending on market movements. However, the stock price might appreciate and give good returns over the long term. So, it is safe to invest in Lupin if you have a long-term horizon.

What is the current market value per stock of Lupin stocks?

As of 13:15 hours on 12th May 2023, the current market value is rupees 773 on the BSE and rupees 773.10 on the NSE.

Does Lupin have any debts?

Yes, Lupin has debt in its balance sheet. As of 31st March 2023, Lupin had secured loans worth rupees 613.46 crores.

Will Lupin's stock price increase?

While Lupin is trading at rupees 773 on 12th May 2023, its lower circuit is quoted at rupees 688.45, and the upper circuit is at rupees 841.35. Considering the upper circuit, the company’s stock price is expected to increase. Moreover, if you stay invested over a long-term horizon, you can witness a gain in the stock price as the short-term volatilities smoothen out and the company grows.

What is the business plan of Lupin?

Lupin aims to expand its domestic and international business with increased manufacturing of its popular drugs. The company specifically targeted growth in the US and China which would boost its revenue and profitability.